Researchers attack Mekong malaria superbug on multiple fronts
Medical researchers are inching their way across the fringes of five Southeast Asian countries to test a triple combination therapy of antimalarial drugs. Results from the trial, being conducted in rural corners of Cambodia, Laos, Myanmar, Thailand and Vietnam, are due by mid-2018, according to the Mahidol Oxford Tropical Medicine Research Unit (MORU), the Bangkok-based group conducting the tests.
MARWAAN MACAN-MARKAR
